Cardiopulmonary Stress Testing Systems Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027

Published: Jan 2023

Pages: 176

SKU: IRTNTR41564

Snapshot

The cardiopulmonary stress testing systems market is estimated to grow at a CAGR of 6.92% between 2022 and 2027. The size of the market is forecast to increase by USD 2,103.24 million. The growth of the market depends on several factors, including the increasing number of heart specialty centers, rising incidence of cardiac diseases and growth of insurance providers, and increasing prevalence of CVDs.

This report extensively covers market segmentation by product (CPET systems, stress ECG, spect systems, stress blood pressure monitors, and pulse oximeters), end-user (hospitals, ambulatory surgical centers, and diagnostic centers), and geography (North America, Europe, Asia, and Rest of World (ROW). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the size of the Cardiopulmonary Stress Testing Systems Market During the Forecast Period?

To learn more about this report, Download Report Sample

Parent Market Analysis

Technavio categorizes the global cardiopulmonary stress testing systems market as a part of the global healthcare equipment market. The parent global healthcare equipment market covers products and companies engaged in the research and development of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Cardiopulmonary Stress Testing Systems Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing number of heart specialty centers is notably driving the market growth, although factors such as the high cost of stress testing devices may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Cardiopulmonary Stress Testing Systems Market Driver

The increasing number of heart specialty centers is notably driving market growth. The growing prevalence of CVDs across the globe is driving the growth of cardiac specialty centers, mainly in developed countries. The rising need to diagnose and treat CVDs is driving the demand for specialized outpatient cardiovascular centers. These centers/clinics offer the diagnosis and treatment of various CVDs, such as heart failure, hypertrophic cardiomyopathy, atrial fibrillation, hypertension, and valvular heart disease. The main aim of these clinics is to provide improved clinical outcomes at reduced costs and fulfill the need of patients.

These clinics are equipped with advanced devices for various diagnostic purposes. The availability of licensed and skilled physicians and other healthcare personnel in specialty cardiac centers has a positive impact on the clinical workflow and patient outcomes. Therefore, the rising number of specialized heart centers is expected to spur the growth of the global market during the forecast period.

Significant Cardiopulmonary Stress Testing Systems Market Trend

The growing integration of technologies is an emerging trend in the market. The global market has been witnessing an increase in the adoption of new technology platforms. Most providers have started focusing on virtual platforms to enable easy and better diagnoses from any location. Individuals and doctors are benefiting significantly from digital health devices and mobile health applications. Heart rate monitoring devices, coupled with mobile health applications, are likely to be adopted by many consumers and will have a positive effect on the healthcare industry. The development of new monitoring technologies has helped in improving disease diagnosis and treatment.

Technological advances have also allowed the flexibility and portability of these systems. Continuous digitization of record systems in physicians' offices and cardiology departments has led vendors to improve data connectivity for a range of management solutions. For instance, the CASE exercise testing system by GE HealthCare Technologies Inc. (GE Healthcare) enables quick and easy access to cardiac functions during exercise for better diagnostic confidence. Thus, technological advances in heart rate monitoring devices and their integration with other compatible technologies will have a positive impact on the growth of the global market during the forecast period.

Major Cardiopulmonary Stress Testing Systems Market Challenge

The high cost of stress-testing devices is a major challenge impeding market growth. Cardiopulmonary stress testing is performed in hospitals, clinics, and diagnostic laboratories to diagnose and assess patients with CVDs. The systems used for cardiopulmonary stress testing are expensive, owing to which medium and small hospitals and clinics find it difficult to purchase such products. The high cost of these systems also restricts their use in home care settings and small clinical laboratories. It may impact the cost of the overall diagnosis procedure. The cost of the systems used for stress testing varies depending on the type of product used for the diagnosis.

Furthermore, stress tests coupled with echocardiography or nuclear imaging are more expensive, which increases the out-of-pocket expenses of patients. Moreover, the radiation exposure from the radionuclide imaging used during the nuclear stress test (myocardial perfusion scan) carries more risks, which may limit the acceptance of this test among patients. These factors are expected to hamper the growth of the global market during the forecast period.

Key Cardiopulmonary Stress Testing Systems Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Cardiopulmonary Stress Testing Systems Market Customer Landscape

Who are the Major Cardiopulmonary Stress Testing Systems Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Biosensors International Group Ltd. - The company operates under one segment. The company under this segment offers pioneering technology and proprietary technology. The key offerings of the company include various cardiopulmonary stress testing systems.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Cardiopulmonary Stress Testing Systems Market?

The market share growth by the CPET segment will be significant during the forecast period. The CPET is used for the evaluation of the cardiopulmonary system. CPET, also known as CPX, is a noninvasive cardiopulmonary stress testing method designed to evaluate the activity of the heart and lungs during exercise. CPET is considered the gold standard by physicians for the functional assessment and evaluation of patients with chronic heart failure.

Get a glance at the market contribution of various segments Request a PDF Sample

The CPET systems segment was valued at USD 1,818.28 million in 2017 and continued to grow until 2021. CPET is an advanced diagnostic tool that can help physicians assess consolidative exercise responses involving the pulmonary, cardiovascular, and skeletal muscle systems. This test is widely used for a broad range of clinical applications for the evaluation of undiagnosed exercise intolerance and the determination of functional impairments. CPET systems are mainly used for CPET testing. Lightweight and portable CPET systems are mainly used in hospitals and clinics for cardiopulmonary stress testing. The increasing use of CPET systems as a validated tool for the diagnosis of patients with heart failure and the capability of these systems to perform distinct assessments by simplifying the precise and reliable measurement of the functional capacity of patients are the major factors fueling the adoption of these systems by physicians. Vendors in the global market are also focusing on the development of CPET systems. Hence, these factors will drive the growth of the global market during the forecast period.

Which are the Key Regions for the Cardiopulmonary Stress Testing Systems Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

North America accounted for the major share of the global market in 2022. This is mainly due to the rapid growth in the number of cardiac specialty centers and the favorable reimbursement scenario in the region. The high prevalence of CVDs in this region, coupled with the presence of skilled physicians to conduct advanced diagnostic procedures, is likely to drive the market in North America during the forecast period. Government organizations and other private organizations are taking various initiatives, such as funding and program launches, to increase the awareness of CVDs in North America. In the US, the American Heart Association (AHA) observed February 2022 as American Heart Month, which is a federally designated event to promote awareness about heart diseases and their early diagnosis. Such initiatives support the research on diagnosis and treatment procedures for evaluating and treating heart diseases. This is expected to augment the growth of the market in the region during the forecast period.

Favorable initiatives in North American countries are driving the growth of the market in the region. The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) has developed an awareness program, The Heart Truth, to create awareness of heart diseases. With the help of this program, the National Heart, Lung, and Blood Institute works with national and community organizations and provides educational materials for the public and health professionals to increase awareness of heart diseases, especially among women, in the US. This will help in increasing the screening and diagnostic procedures for heart diseases and fuel the growth of the market in North America during the forecast period.

In 2020, with the outbreak of COVID-19, the regional market registered low growth. However, in 2021, with the gradual decline in the number of COVID-19 cases, lockdowns were lifted, leading to the resumption of non-essential services in hospitals, health clinics, and manufacturing units. This will fuel the demand for cardiopulmonary stress testing systems and drive the growth of the regional market during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Product Outlook (USD Million, 2017 - 2027)
- CPET systems
- Stress ECG
- SPECT systems
- Stress blood pressure monitors
- Pulse oximeters

End-user Outlook (USD Million, 2017 - 2027)
- Hospitals
- Ambulatory surgical centers
- Diagnostic centers

Region Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
  - Argentina
  - Others
- Rest of World
  - Saudi Arabia
  - South Africa
  - Brazil
  - Others

Cardiopulmonary Stress Testing Systems Market Scope
Report Coverage	Details
Page number	176
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 6.92%
Market growth 2023-2027	USD 2,103.24 million
Market structure	Fragmented
YoY growth 2022-2023(%)	6.12
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 36%
Key countries	US, Germany, France, UK, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Becton Dickinson and Co., Biosensors International Group Ltd., Cardinal Health Inc., COSMED Srl, Fukuda Denshi Co. Ltd., General Electric Co., Halma Plc, Hill Rom Holdings Inc., Koninklijke Philips NV, MGC Diagnostics Corp., Nasiff Associates Inc., Neurosoft, Nihon Kohden Corp., Nonin Medical Inc., OSI Systems Inc., SCHILLER AG, Siemens Healthineers AG, SunTech Medical Inc., Thermo Fisher Scientific Inc., and Vyaire Medical Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Cardiopulmonary Stress Testing Systems Market Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the cardiopulmonary stress testing systems market between 2023 and 2027
Precise estimation of the size of the cardiopulmonary stress testing systems market size and its contribution to the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of cardiopulmonary stress testing systems market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global cardiopulmonary stress testing systems market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global cardiopulmonary stress testing systems market 2017 - 2021 ($ million)

4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 CPET systems - Market size and forecast 2022-2027
- Exhibit 34: Chart on CPET systems - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on CPET systems - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on CPET systems - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on CPET systems - Year-over-year growth 2022-2027 (%)

6.4 Stress ECG - Market size and forecast 2022-2027
- Exhibit 38: Chart on Stress ECG - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Stress ECG - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Stress ECG - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Stress ECG - Year-over-year growth 2022-2027 (%)

6.5 SPECT systems - Market size and forecast 2022-2027
- Exhibit 42: Chart on SPECT systems - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on SPECT systems - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on SPECT systems - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on SPECT systems - Year-over-year growth 2022-2027 (%)

6.6 Stress blood pressure monitors - Market size and forecast 2022-2027
- Exhibit 46: Chart on Stress blood pressure monitors - Market size and forecast 2022-2027 ($ million)
- Exhibit 47: Data Table on Stress blood pressure monitors - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Chart on Stress blood pressure monitors - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Stress blood pressure monitors - Year-over-year growth 2022-2027 (%)

6.7 Pulse oximeters - Market size and forecast 2022-2027
- Exhibit 50: Chart on Pulse oximeters - Market size and forecast 2022-2027 ($ million)
- Exhibit 51: Data Table on Pulse oximeters - Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Chart on Pulse oximeters - Year-over-year growth 2022-2027 (%)
- Exhibit 53: Data Table on Pulse oximeters - Year-over-year growth 2022-2027 (%)

6.8 Market opportunity by Product
- Exhibit 54: Market opportunity by Product ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 55: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 56: Data Table on End-user - Market share 2022-2027 (%)

7.2 Comparison by End-user
- Exhibit 57: Chart on Comparison by End-user
- Exhibit 58: Data Table on Comparison by End-user

7.3 Hospitals - Market size and forecast 2022-2027
- Exhibit 59: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 60: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 62: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

7.4 Ambulatory surgical centers - Market size and forecast 2022-2027
- Exhibit 63: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)

7.5 Diagnostic centers - Market size and forecast 2022-2027
- Exhibit 67: Chart on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on Diagnostic centers - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on Diagnostic centers - Year-over-year growth 2022-2027 (%)

7.6 Market opportunity by End-user
- Exhibit 71: Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 73: Chart on Market share by geography 2022-2027 (%)
- Exhibit 74: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 75: Chart on Geographic comparison
- Exhibit 76: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027
- Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 France - Market size and forecast 2022-2027
- Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
- Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)

9.10 UK - Market size and forecast 2022-2027
- Exhibit 105: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 107: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 108: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.11 Japan - Market size and forecast 2022-2027
- Exhibit 109: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 110: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 111: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 112: Data Table on Japan - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 113: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 114: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 115: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 116: Overview on factors of disruption

11.4 Industry risks
- Exhibit 117: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 118: Vendors covered

12.2 Market positioning of vendors
- Exhibit 119: Matrix on vendor position and classification

12.3 Biosensors International Group Ltd.
- Exhibit 120: Biosensors International Group Ltd. - Overview
- Exhibit 121: Biosensors International Group Ltd. - Product / Service
- Exhibit 122: Biosensors International Group Ltd. - Key offerings

12.4 Cardinal Health Inc.
- Exhibit 123: Cardinal Health Inc. - Overview
- Exhibit 124: Cardinal Health Inc. - Business segments
- Exhibit 125: Cardinal Health Inc. - Key news
- Exhibit 126: Cardinal Health Inc. - Key offerings
- Exhibit 127: Cardinal Health Inc. - Segment focus

12.5 COSMED Srl
- Exhibit 128: COSMED Srl - Overview
- Exhibit 129: COSMED Srl - Product / Service
- Exhibit 130: COSMED Srl - Key offerings

12.6 Fukuda Denshi Co. Ltd.
- Exhibit 131: Fukuda Denshi Co. Ltd. - Overview
- Exhibit 132: Fukuda Denshi Co. Ltd. - Business segments
- Exhibit 133: Fukuda Denshi Co. Ltd. - Key offerings
- Exhibit 134: Fukuda Denshi Co. Ltd. - Segment focus

12.7 General Electric Co.
- Exhibit 135: General Electric Co. - Overview
- Exhibit 136: General Electric Co. - Business segments
- Exhibit 137: General Electric Co. - Key news
- Exhibit 138: General Electric Co. - Key offerings
- Exhibit 139: General Electric Co. - Segment focus

12.8 Halma Plc
- Exhibit 140: Halma Plc - Overview
- Exhibit 141: Halma Plc - Business segments
- Exhibit 142: Halma Plc - Key news
- Exhibit 143: Halma Plc - Key offerings
- Exhibit 144: Halma Plc - Segment focus

12.9 Hill Rom Holdings Inc.
- Exhibit 145: Hill Rom Holdings Inc. - Overview
- Exhibit 146: Hill Rom Holdings Inc. - Business segments
- Exhibit 147: Hill Rom Holdings Inc. - Key news
- Exhibit 148: Hill Rom Holdings Inc. - Key offerings
- Exhibit 149: Hill Rom Holdings Inc. - Segment focus

12.10 Koninklijke Philips NV
- Exhibit 150: Koninklijke Philips NV - Overview
- Exhibit 151: Koninklijke Philips NV - Business segments
- Exhibit 152: Koninklijke Philips NV - Key news
- Exhibit 153: Koninklijke Philips NV - Key offerings
- Exhibit 154: Koninklijke Philips NV - Segment focus

12.11 MGC Diagnostics Corp.
- Exhibit 155: MGC Diagnostics Corp. - Overview
- Exhibit 156: MGC Diagnostics Corp. - Product / Service
- Exhibit 157: MGC Diagnostics Corp. - Key offerings

12.12 Nihon Kohden Corp.
- Exhibit 158: Nihon Kohden Corp. - Overview
- Exhibit 159: Nihon Kohden Corp. - Product / Service
- Exhibit 160: Nihon Kohden Corp. - Key news
- Exhibit 161: Nihon Kohden Corp. - Key offerings

12.13 Nonin Medical Inc.
- Exhibit 162: Nonin Medical Inc. - Overview
- Exhibit 163: Nonin Medical Inc. - Product / Service
- Exhibit 164: Nonin Medical Inc. - Key news
- Exhibit 165: Nonin Medical Inc. - Key offerings

12.14 OSI Systems Inc.
- Exhibit 166: OSI Systems Inc. - Overview
- Exhibit 167: OSI Systems Inc. - Business segments
- Exhibit 168: OSI Systems Inc. - Key offerings
- Exhibit 169: OSI Systems Inc. - Segment focus

12.15 SCHILLER AG
- Exhibit 170: SCHILLER AG - Overview
- Exhibit 171: SCHILLER AG - Product / Service
- Exhibit 172: SCHILLER AG - Key offerings

12.16 Siemens Healthineers AG
- Exhibit 173: Siemens Healthineers AG - Overview
- Exhibit 174: Siemens Healthineers AG - Business segments
- Exhibit 175: Siemens Healthineers AG - Key news
- Exhibit 176: Siemens Healthineers AG - Key offerings
- Exhibit 177: Siemens Healthineers AG - Segment focus

12.17 Vyaire Medical Inc.
- Exhibit 178: Vyaire Medical Inc. - Overview
- Exhibit 179: Vyaire Medical Inc. - Product / Service
- Exhibit 180: Vyaire Medical Inc. - Key news
- Exhibit 181: Vyaire Medical Inc. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 182: Inclusions checklist
- Exhibit 183: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 184: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 185: Research methodology
- Exhibit 186: Validation techniques employed for market sizing
- Exhibit 187: Information sources

13.5 List of abbreviations
- Exhibit 188: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

cardiopulmonary stress testing systems market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis